summary
Introduced
01/23/2017
01/23/2017
In Committee
01/23/2017
01/23/2017
Crossed Over
Passed
Dead
12/31/2018
12/31/2018
Introduced Session
190th General Court
Bill Summary
Relative to opioid drug manufacturer assessments. Mental Health, Substance Use and Recovery.
AI Summary
This bill establishes an assessment on manufacturers of opioid drugs in Massachusetts to fund prevention, treatment, management, and research related to opioid addiction. The assessment is calculated based on each manufacturer's annual distribution and dispensing of opioid drugs in the state, with a total assessment cap of $15 million. The funds collected will be deposited into the Opioid Treatment and Addiction Prevention Fund, which the Department of Public Health will administer to support the stated purposes. The bill requires the department to promulgate regulations to implement the assessment within 180 days and sets the effective date for the assessment at June 30, 2018.
Committee Categories
Health and Social Services
Sponsors (34)
Michael Brady (D),
James Cantwell (D),
Gerry Cassidy (D),
Mike Connolly (D),
Claire Cronin (D),
Josh Cutler (D),
Shawn Dooley (R),
Carolyn Dykema (D),
Lori Ehrlich (D),
Tricia Farley-Bouvier (D),
Carole Fiola (D),
Bill Galvin (D),
Sean Garballey (D),
Colleen Garry (D),
Carmine Gentile (D),
Carlos González (D),
Danielle Gregoire (D),
Dan Hunt (D),
Randy Hunt (R),
Louis Kafka (D),
Hannah Kane (R),
Mary Keefe (D),
Kay Khan (D),
Juana Matias (D),
Mark Montigny (D),
Matt Muratore (R),
Brian Murray (D),
Jim O'Day (D),
Sarah Peake (D),
Elizabeth Poirier (R),
Dave Rogers (D),
Jeff Roy (D),
Aaron Vega (D),
Bud Williams (D),
Last Action
Accompanied a study order, see H4710 (on 07/09/2018)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://malegislature.gov/Bills/190/H3508 |
| Bill | https://malegislature.gov/Bills/190/H3508.pdf |
Loading...